Luigi Pascarella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Luigi Pascarella has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Mark A. Farber
Division of Vascular Surgery, Department of Surgery, University of North Carolina, 3021 Burnett Womack Bldg, CB #7212, Chapel Hill, NC 27599, USA
4 shared publications- Maen Aboul Hosn
The University of Iowa Hospitals and Clinics
3 shared publications Colby Ruiz
Division of Vascular Surgery, Department of Surgery, University of North Carolina, 3021 Burnett Womack Bldg, CB #7212, Chapel Hill, NC 27599, USA
2 shared publicationsEmilie D. Duchesneau
Department of Epidemiology, Gillings School of Global Public Health, of North Carolina at Chapel Hill, Chapel Hill, North Carolina
2 shared publicationsJacob Wood
Division of Vascular Surgery, Department of Surgery, University of North Carolina, 3021 Burnett Womack Bldg, CB #7212, Chapel Hill, NC 27599, USA
2 shared publicationsKatharine L. McGinigle
Department of Vascular Surgery, University of North Carolina School of Medicine, Chapel Hill, NC
2 shared publications
Latest Publications
- 1 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (2) , 365-372.e1
Current outcomes following upper and lower extremity arterial trauma from the National Trauma Data Bank
- 1 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (2) , 365-372.e1
Current outcomes following upper and lower extremity arterial trauma from the National Trauma Data Bank
- 16 February 2024
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 37 (1) , 26-34
Upper-limb neurovascular compression, pectoralis minor and quadrilateral space syndromes: A narrative review of current literature
- 16 February 2024
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 37 (1) , 26-34
Upper-limb neurovascular compression, pectoralis minor and quadrilateral space syndromes: A narrative review of current literature
- 5 April 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 288, 215-224
Preferred Feedback Styles Among Different Groups in an Academic Medical Center
- 5 April 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 288, 215-224
Preferred Feedback Styles Among Different Groups in an Academic Medical Center
- 20 September 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 89, 190-199
Trends and Outcomes in Management of Thoracic Aortic Injury in Children, Adolescent, and Mature Pediatric Patients Using Data from the National Trauma Data Bank
- 20 September 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 89, 190-199
Trends and Outcomes in Management of Thoracic Aortic Injury in Children, Adolescent, and Mature Pediatric Patients Using Data from the National Trauma Data Bank
- 20 May 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 86, 199-209
Gender Disparities in Aortoiliac Revascularization in Patients with Aortoiliac Occlusive Disease
- 20 May 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 86, 199-209
Gender Disparities in Aortoiliac Revascularization in Patients with Aortoiliac Occlusive Disease
- 1 July 2020
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 30 (7) , 737-741
Supraclavicular Versus Transaxillary First Rib Resection for Thoracic Outlet Syndrome
Background: Thoracic outlet syndrome (TOS) results from compression of neurovascular structures supplying the upper extremity as they exit the thoracic outlet. Depending on the clinical presentation, surgical decompression may be required. Objectives: Transaxillary (TA) and supraclavicular (SC) approaches are both widely utilized and deemed effective. Our objective was to review the outcomes for both approaches at our institution. Methods: A retrospective review was conducted on patients who underwent thoracic outlet decompression between 2010 and 2015. Data on demographics, comorbidities, presenting symptoms, and type of TOS (neurogenic, venous, or arterial) were collected. Operative times, length of hospital stay, perioperative complications, and outcomes were also studied. Results: A total of 82 thoracic outlet decompression procedures were performed during the study period: 42% neurogenic TOS, 46% venous TOS, and 12% arterial TOS. In total, 49% underwent TA approach and 51% underwent SC approach. Adjunct procedures were performed in 13% of patients. There were no significant differences in average operative time (151.3 ± 54.1 minutes versus 126.1 ± 36.1 minutes, P = .11) or hospital stay (2.3 ± 1.9 days versus 2.4 ± 1.4 days, P = .23) between both groups, respectively. Minor complications were seen in 6% of patients with no significant difference in both groups, whereas 6% had major complications. No perioperative or 30-day mortalities were observed. In total, 49% of patients had complete resolution of symptoms, 46% had partial improvement, and 5% had no improvement. There was no difference in symptom resolution between either group. Conclusions: TA and SC approaches are equally safe and effective for the treatment of TOS. SC decompression allows for adjunct procedures and vascular reconstructions.
- 1 July 2020
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 30 (7) , 737-741
Supraclavicular Versus Transaxillary First Rib Resection for Thoracic Outlet Syndrome
Background: Thoracic outlet syndrome (TOS) results from compression of neurovascular structures supplying the upper extremity as they exit the thoracic outlet. Depending on the clinical presentation, surgical decompression may be required. Objectives: Transaxillary (TA) and supraclavicular (SC) approaches are both widely utilized and deemed effective. Our objective was to review the outcomes for both approaches at our institution. Methods: A retrospective review was conducted on patients who underwent thoracic outlet decompression between 2010 and 2015. Data on demographics, comorbidities, presenting symptoms, and type of TOS (neurogenic, venous, or arterial) were collected. Operative times, length of hospital stay, perioperative complications, and outcomes were also studied. Results: A total of 82 thoracic outlet decompression procedures were performed during the study period: 42% neurogenic TOS, 46% venous TOS, and 12% arterial TOS. In total, 49% underwent TA approach and 51% underwent SC approach. Adjunct procedures were performed in 13% of patients. There were no significant differences in average operative time (151.3 ± 54.1 minutes versus 126.1 ± 36.1 minutes, P = .11) or hospital stay (2.3 ± 1.9 days versus 2.4 ± 1.4 days, P = .23) between both groups, respectively. Minor complications were seen in 6% of patients with no significant difference in both groups, whereas 6% had major complications. No perioperative or 30-day mortalities were observed. In total, 49% of patients had complete resolution of symptoms, 46% had partial improvement, and 5% had no improvement. There was no difference in symptom resolution between either group. Conclusions: TA and SC approaches are equally safe and effective for the treatment of TOS. SC decompression allows for adjunct procedures and vascular reconstructions.
- 1 May 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (3) , 396-404
Operative strategies for inferior vena cava repair in oncologic surgery
- 1 May 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (3) , 396-404
Operative strategies for inferior vena cava repair in oncologic surgery
- 1 May 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28 (5) , 562-568
Minimally Invasive Management of Severe Aortoiliac Occlusive Disease
Background: Peripheral arterial disease (PAD) is a complex and highly prevalent pathology. It has been estimated that ∼8.5 million people in the United States are affected by PAD, of which 12%–20% are older than age 60. The TransAtlantic Inter-Society Consensus (TASC) guidelines classified aortoiliac atherosclerotic disease based on morphology and level of lesions. TASC II guidelines recommend bilateral surgical bypass to the femoral arteries for TASC II C and D lesions. The aortobifemoral bypass (ABF) has been considered the gold standard in the treatment of aortoiliac occlusive disease (AIOD). The long-term patency rate of 85%–90% at 5 years and 75%–80% at 10 years has been for a long time unmatched by other methods of revascularization. Methods: This is a review of the current literature regarding minimally invasive strategies in the care of TASC II C and D aortoiliac disease. Results: Endovascular therapies have led to a paradigm change even in the treatment of highly advanced lesions. Reconstruction of the aortic bifurcation for distal aortic and/or ostial unilateral/bilateral common iliac artery disease can be achieved via the deployment of stents with “kissing” technique and aortic endografts. Laparoscopic aortoiliac surgery for TASC II C and D lesions was first proposed in 1993. Total laparoscopic, laparoscopic-assisted, and laparobotic techniques have been described. Minimal incision aortic surgery (MIAS) describes abdominal incisions varying from 6 to 12 cm and positional adjustment of retractors to access the retroperitoneum for infrarenal aortic aneurysms and/or AIOD. Conclusions: Although initial enthusiasm laparoscopic aortic surgery and MIAS have failed to gain acceptance in the vascular surgery community due to intrinsic procedural challenges, they are currently practiced in few highly specialized centers. At this moment, high-quality evidence is lacking regarding the further feasibility of these techniques and their applicability in general practice compared to endovascular therapies. While the ABF remains still the optimal choice in select, fit for surgery patients, endovascular therapies offer a less invasive approach that may provide a mortality and morbidity benefit in higher risk patients with acceptable short- and long-term outcomes.
- 1 May 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28 (5) , 562-568
Minimally Invasive Management of Severe Aortoiliac Occlusive Disease
Background: Peripheral arterial disease (PAD) is a complex and highly prevalent pathology. It has been estimated that ∼8.5 million people in the United States are affected by PAD, of which 12%–20% are older than age 60. The TransAtlantic Inter-Society Consensus (TASC) guidelines classified aortoiliac atherosclerotic disease based on morphology and level of lesions. TASC II guidelines recommend bilateral surgical bypass to the femoral arteries for TASC II C and D lesions. The aortobifemoral bypass (ABF) has been considered the gold standard in the treatment of aortoiliac occlusive disease (AIOD). The long-term patency rate of 85%–90% at 5 years and 75%–80% at 10 years has been for a long time unmatched by other methods of revascularization. Methods: This is a review of the current literature regarding minimally invasive strategies in the care of TASC II C and D aortoiliac disease. Results: Endovascular therapies have led to a paradigm change even in the treatment of highly advanced lesions. Reconstruction of the aortic bifurcation for distal aortic and/or ostial unilateral/bilateral common iliac artery disease can be achieved via the deployment of stents with “kissing” technique and aortic endografts. Laparoscopic aortoiliac surgery for TASC II C and D lesions was first proposed in 1993. Total laparoscopic, laparoscopic-assisted, and laparobotic techniques have been described. Minimal incision aortic surgery (MIAS) describes abdominal incisions varying from 6 to 12 cm and positional adjustment of retractors to access the retroperitoneum for infrarenal aortic aneurysms and/or AIOD. Conclusions: Although initial enthusiasm laparoscopic aortic surgery and MIAS have failed to gain acceptance in the vascular surgery community due to intrinsic procedural challenges, they are currently practiced in few highly specialized centers. At this moment, high-quality evidence is lacking regarding the further feasibility of these techniques and their applicability in general practice compared to endovascular therapies. While the ABF remains still the optimal choice in select, fit for surgery patients, endovascular therapies offer a less invasive approach that may provide a mortality and morbidity benefit in higher risk patients with acceptable short- and long-term outcomes.
- 30 September 2017
- Published by Springer Nature
- p. 99-102
Luigi Pascarella